Any updates on Restructuring Groups / Tiers?
The latest forum is over 2 years old. More updated information would be great, especially regarding PWP, Miller Buckfire, Ducera, Centerview, Moelis.
I'm just a SA from a major RX shop. So I'm speaking from a more junior perspective and please correct me if I'm wrong:
PWP-used to be Okay on RX but has weak deal flow in recent years. And analysts in PWP are generalist so you may not get much RX exposure. Miller Buckfire-slowly dieing. Half of MDs already left to (CTW, Ducera, EVR, Millstein...) Ducera-decent deal flow consider its small size. Positive growth outlook. But right now I don't think they have the best RX talent on analyst level. Centerview-They are building a strong RX franchise and I heard they rx group hires 1st year analyst out of its generalist pool. Moelis-Strong and growing RX. MoCo is competing with PJT/LZD/HL globally. Tier 1.5, if not Tier 1.
Ranking for entry level RX: Moelis>or=Centerview>Ducera>PWP>Miller Buckfire
Wow thanks. What other banks do RX?
Top firms
Top: HL RX, PJT RX (I believe both recruit seperately from M&A generalist)
Followed by Lazard, Rothschild, Evercore.
Rest are firms like Moelis, MB (dying), Ducera
PWP as previous poster was good but had an exodus two years ago with the spinoff of Ducera. Greenhill was good but has been in decline, Ducera poached their top RX guy one or two years ago.
Sed voluptas labore voluptate neque quia. Rerum quasi a repudiandae cum iusto.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...